Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MASS
MASS logo

MASS Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
9.000
Open
9.000
VWAP
8.59
Vol
337.09K
Mkt Cap
177.60M
Low
8.360
Amount
2.90M
EV/EBITDA(TTM)
--
Total Shares
--
EV
139.26M
EV/OCF(TTM)
--
P/S(TTM)
3.99
908 Devices Inc. is revolutionizing chemical analysis with its simple handheld and desktop devices, addressing life-altering applications. Its devices are used at the point-of-need to interrogate unknown and invisible materials and provide actionable answers to directly address some of the critical problems in forensics, bioprocessing, pharma/biopharma, life science research and adjacent markets. Its forensics & field detection products include MX908, XplorIR, ProtectIR, ThreatID, and InterceptIR. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. XplorIR is a handheld gas detector that can detect and quantify unknown chemicals and vapors in seconds.
Show More

Events Timeline

(ET)
2026-05-06
07:40:00
Company Reports Q1 Revenue of $13.4M, Acquires NIRLAB AG
select
2026-05-06
07:30:00
908 Devices Completes Acquisition of NIRLAB AG for $15 Million
select
2026-04-21 (ET)
2026-04-21
17:10:00
908 Devices Appoints Kola Otitoju as Chief Business & Strategy Officer
select
2026-03-09 (ET)
2026-03-09
07:00:00
908 Devices Files $100M Mixed Securities Shelf
select
2026-03-03 (ET)
2026-03-03
07:20:00
908 Devices Expects 2026 Revenues of $64.5M to $67.5M
select
2026-03-03
07:20:00
908 Devices Reports Q4 Revenue of $17.38M
select
2026-01-20 (ET)
2026-01-20
16:20:00
Major Averages Drop as Trump Revives Tariff Threats
select
2026-01-20
12:10:00
Major Averages Broadly Lower, Gold Hits Record Highs
select

News

seekingalpha
9.5
05-06seekingalpha
908 Devices Reports Strong Q1 2026 Earnings and Strategic Acquisition
  • Significant Revenue Growth: 908 Devices reported total revenue of $13.4 million for Q1 2026, reflecting a 14% increase year-over-year, driven by strong demand from U.S. state and local customers, which accounted for approximately 50% of total revenues, indicating enhanced market competitiveness.
  • Strategic Acquisition Announced: The company announced the acquisition of NIRLAB AG for a total transaction value of $15 million, comprising $13 million in cash and $2 million in equity, expected to increase international revenue and introduce a high-retention subscription model, thereby expanding market share.
  • Upgraded Outlook: 908 Devices raised its 2026 revenue guidance to a range of $67 million to $70 million, with handheld product and service revenue projected to grow 18% to 21% year-over-year, laying a solid foundation for future growth.
  • Leadership Team Expansion: The appointment of Kola Otitoju as Chief Business and Strategy Officer aims to enhance the depth and execution capability of the leadership team, supporting the company's long-term strategic goals and market expansion plans.
seekingalpha
9.5
05-06seekingalpha
908 Devices Q1 Earnings Beat Expectations with Strong Guidance
  • Earnings Performance: 908 Devices reported a Q1 GAAP EPS of -$0.32, missing estimates by $0.10, yet achieved revenue of $13.38 million, reflecting a 13.6% year-over-year increase and beating expectations by $0.22 million, indicating resilience in the market.
  • Recurring Revenue Growth: The recurring revenue for the quarter was $4.0 million, accounting for 30% of total revenues, which signifies a notable advancement in the company's stable revenue sources, enhancing future financial stability.
  • Gross Margin Performance: The adjusted gross margin stood at 57%, showcasing the company's success in cost control and operational efficiency, which further supports its profitability enhancement.
  • 2026 Guidance: 908 Devices now expects full-year 2026 revenues to range between $67.0 million and $70.0 million, an upward revision from previous estimates, reflecting strong confidence in future growth, with anticipated growth of 19% to 25%, exceeding the consensus of $65.94 million.
Newsfilter
9.5
05-06Newsfilter
908 Devices Reports 14% Revenue Growth in Q1 2026
  • Significant Revenue Growth: 908 Devices reported revenue of $13.4 million for Q1 2026, marking a 14% year-over-year increase driven by higher sales in mass spectrometry and an optimized FTIR product mix, thereby enhancing the company's competitive edge in the chemical analysis market.
  • Strategic Acquisition: The acquisition of NIRLAB AG aims to broaden the company's reach in the low-cost narcotics detection market while increasing recurring revenue through software subscriptions, reflecting the company's commitment to disciplined growth investments and strategic execution.
  • Improved Gross Margin: The adjusted gross margin for Q1 reached 57%, a 290 basis point improvement from the prior year, primarily due to increased product revenues and optimized channel mix, indicating enhanced cost control and profitability.
  • Strong Financial Position: As of March 31, 2026, the company reported cash and cash equivalents of $111.7 million with no debt, demonstrating robust financial health while continuing to invest in and expand its business operations.
Newsfilter
5.0
04-21Newsfilter
908 Devices Appoints New Chief Business & Strategy Officer
  • Executive Appointment: 908 Devices announces the appointment of Kola Otitoju as Chief Business & Strategy Officer, overseeing product and corporate strategy, business development, and M&A to expand the company's market presence in public health, safety, and defense tech.
  • Extensive Experience: Otitoju brings over 25 years of executive leadership, having served as Senior VP at Repligen Corporation where he drove a 20% compound annual growth rate and executed over 15 M&A transactions, showcasing his capability in fostering company growth.
  • Equity Incentive Plan: As an inducement, 908 Devices granted Otitoju 110,193 restricted stock units (RSUs) and options for 146,789 shares, with RSUs vesting over three years and an exercise price of $7.26 per share, reflecting the company's commitment to his long-term contributions.
  • Strategic Development: CEO Kevin J. Knopp stated that Otitoju's appointment will accelerate strategic initiatives and strengthen partnerships, aiming to enhance the company's competitiveness in the rapidly evolving chemical analysis market.
Newsfilter
1.0
03-16Newsfilter
908 Devices CEO to Present at Sidoti Small Cap Conference
  • Conference Details: 908 Devices' CEO Kevin J. Knopp and CFO Joe Griffith will participate in the Sidoti Small Cap Conference on March 18, 2026, starting at 1:45 p.m. Eastern Time, aimed at attracting investor interest in the company's growth trajectory.
  • Live Webcast: The event will feature a live audio webcast, allowing investors to access an archived version through the company's 'Investors' section, enhancing interaction and transparency between the company and potential investors.
  • Technological Innovation: 908 Devices focuses on developing handheld chemical analysis tools that leverage advanced analytical technologies, software automation, and machine learning to address critical health, safety, and defense issues, particularly in combating the fentanyl and illicit drug crisis.
  • Market Positioning: The company aims to provide rapid, actionable analytical results in vital health and safety applications, showcasing its strategic significance in addressing global security threats and toxic carcinogen exposure, thereby reinforcing its market leadership.
seekingalpha
9.5
03-03seekingalpha
908 Devices Q4 Earnings Exceed Expectations
  • Earnings Highlights: 908 Devices reported a GAAP EPS of $0.11 for Q4 2025, beating expectations by $0.18, which reflects a significant improvement in profitability and boosts investor confidence.
  • Revenue Growth: The company achieved Q4 revenue of $17.38 million, representing a 21.2% year-over-year increase and exceeding market expectations by $1.19 million, indicating strong market demand and sales performance in ongoing operations.
  • Positive Cash Flow: 908 Devices delivered a net income of $4.4 million from continuing operations and a positive Adjusted EBITDA of $0.7 million in Q4, successfully achieving cash flow positivity and further solidifying its financial health.
  • 2026 Guidance: The company expects full-year 2026 revenues to range between $64.5 million and $67.5 million, reflecting a 15% to 20% growth compared to 2025, surpassing the consensus of $65.38 million, demonstrating confidence in future growth prospects.
Wall Street analysts forecast MASS stock price to rise
4 Analyst Rating
Wall Street analysts forecast MASS stock price to rise
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
6.00
Averages
6.00
High
6.00
Current: 0.000
sliders
Low
6.00
Averages
6.00
High
6.00
Stifel
Buy
maintain
$8 -> $10
AI Analysis
2026-05-07
Reason
Stifel
Price Target
$8 -> $10
AI Analysis
2026-05-07
maintain
Buy
Reason
Stifel raised the firm's price target on 908 Devices to $10 from $8 and keeps a Buy rating on the shares.
Leerink
Puneet Souda
Market Perform -> Outperform
upgrade
$12
2025-08-05
Reason
Leerink
Puneet Souda
Price Target
$12
2025-08-05
upgrade
Market Perform -> Outperform
Reason
Leerink analyst Puneet Souda upgraded 908 Devices to Outperform from Market Perform with a $12 price target.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for MASS
Unlock Now

Valuation Metrics

The current forward P/E ratio for 908 Devices Inc (MASS.O) is -3.02, compared to its 5-year average forward P/E of -15.16. For a more detailed relative valuation and DCF analysis to assess 908 Devices Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-15.16
Current PE
-3.02
Overvalued PE
2.30
Undervalued PE
-32.61

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-13.86
Current EV/EBITDA
-0.12
Overvalued EV/EBITDA
6.87
Undervalued EV/EBITDA
-34.59

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
7.36
Current PS
1.07
Overvalued PS
13.22
Undervalued PS
1.50

Financials

AI Analysis
Annual
Quarterly

Whales Holding MASS

A
Arch Venture Partners, L.P.
Holding
MASS
-11.88%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is 908 Devices Inc (MASS) stock price today?

The current price of MASS is 8.41 USD — it has decreased -5.82

What is 908 Devices Inc (MASS)'s business?

908 Devices Inc. is revolutionizing chemical analysis with its simple handheld and desktop devices, addressing life-altering applications. Its devices are used at the point-of-need to interrogate unknown and invisible materials and provide actionable answers to directly address some of the critical problems in forensics, bioprocessing, pharma/biopharma, life science research and adjacent markets. Its forensics & field detection products include MX908, XplorIR, ProtectIR, ThreatID, and InterceptIR. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. XplorIR is a handheld gas detector that can detect and quantify unknown chemicals and vapors in seconds.

What is the price predicton of MASS Stock?

Wall Street analysts forecast MASS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MASS is6.00 USD with a low forecast of 6.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is 908 Devices Inc (MASS)'s revenue for the last quarter?

908 Devices Inc revenue for the last quarter amounts to 11.78M USD, increased 58.68

What is 908 Devices Inc (MASS)'s earnings per share (EPS) for the last quarter?

908 Devices Inc. EPS for the last quarter amounts to 1.23 USD, decreased -472.73

How many employees does 908 Devices Inc (MASS). have?

908 Devices Inc (MASS) has 246 emplpoyees as of May 31 2026.

What is 908 Devices Inc (MASS) market cap?

Today MASS has the market capitalization of 177.60M USD.